Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

July 18, 2025 08:40 ET | Source: SNS Insider pvt ltd

Lymphoma Treatment Market to Surpass USD 14.66 Billion by 2032, Fueled by Immunotherapy Advancements and Emerging Market Expansion - SNS Insider

Austin, July 18, 2025 (GLOBE NEWSWIRE) -- Lymphoma Treatment Market Size & Growth Analysis: According to SNS Insider, the global Lymphoma Treatment Market was valued at USD 7.01 billion in 2023...
June 23, 2025 02:30 ET | Source: Enterome

Enterome presents positive Phase 2 interim results in relapsed/refractory indolent non-Hodgkin lymphoma after EO2463 OncoMimics™ immunotherapy treatment at ICML

60% (12/20) complete response rate after treatment with EO2463 in combination with lenalidomide and rituximab (R2) EO2463 plus R2 was well tolerated in patients with follicular and marginal zone...
March 19, 2024 07:00 ET | Source: Research Nester

Non-Hodgkin Lymphoma Therapeutics Market revenue to hit USD 20 Billion by 2036, says Research Nester

New York , March 19, 2024 (GLOBE NEWSWIRE) -- The global non-hodgkin lymphoma therapeutics market size is projected to grow at a CAGR of over 8% from 2024 to 2036. The market is expected to garner a...
October 25, 2021 07:30 ET | Source: Zai Lab Limited

Zai Lab Announces First Patient Treated in Greater China Portion of Potentially Registrational, Global Phase 2 Study of Odronextamab

SHANGHAI and SAN FRANCISCO and CAMBRIDGE, Mass., Oct. 25, 2021 (GLOBE NEWSWIRE) -- Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688), a patient-focused, innovative, commercial-stage, global...